Results 121 to 130 of about 7,822 (173)

CAR-T Cell Therapy in Glioblastoma: Overcoming Immunological Barriers and Advancing Clinical Translation. [PDF]

Cancer Manag Res
Pourmasoumi P, Pourmasoumi A, Zamani F, Amini A, Shokri S.   +4 more
europepmc   +1 more source

The α-Gal Epitope (Galα1-3Galβ1-4GlcNAc) as Therapeutic Agent in Cancer Immunotherapy, Vaccine Effectiveness Amplification and Injured Tissue Regeneration. [PDF]

Int J Mol Sci
Galili U.
europepmc   +1 more source

Harnessing oncolytic viruses to overcome immunosuppression in breast cancer: from mechanisms to clinical translation. [PDF]

Front Immunol
Xianshu K, Zhonghua L, Junyu D, Qing P, Li Z, Feiyue Z, Xuqing S.   +6 more
europepmc   +1 more source

Oncolytic virus therapy for hepatocellular carcinoma: A bibliometric analysis of research landscapes, hotspots, and clinical transformation trends from 2000 to mid-2025. [PDF]

Hum Vaccin Immunother
Yu F, Yin S, Zhu J, Sun K.
europepmc   +1 more source

Dual-chemokine-armed oncolytic Senecavirus A co-recruits cDC1 and CXCR3⁺ T cells to convert 'cold' melanoma and drive durable regression. [PDF]

J Immunother Cancer
Li W, Sun J, Tian H, Tang X, Gao L, Liang S, Zhang Z, Sun Y, Ma J, Zhao X.   +9 more
europepmc   +1 more source

KLS-3021: Innovative oncolytic virotherapy for the treatment of advanced primary and metastatic cutaneous squamous cell carcinoma. [PDF]

Mol Ther Oncol
Park K, Seo J, Lee S, Kang H, Kim J, Lee E, Shin J, Hong SO, Kim S, Kim SJ.   +9 more
europepmc   +1 more source

Fusing Oncolytic Virotherapy With Cancer Immunotherapy to Treat Therapy-Resistant Melanoma. [PDF]

J Clin Oncol
Vile RG.
europepmc   +1 more source

Polio virotherapy provokes MDA5 signaling and CD4⁺ T cell help to mediate cancer <i>in situ</i> vaccination. [PDF]

Microbiol Mol Biol Rev
Gromeier M, Brown MC.
europepmc   +1 more source

Repurposing the SSRI paroxetine increases lymphocyte mobilization and improves the efficacy of measles virus-based immunovirotherapy. [PDF]

Mol Ther Oncol
Stergiopoulos GM, Concilio SC, Viker KB, Clark SM, Robinson SI, Galanis E.   +5 more
europepmc   +1 more source

Integrating oncolytic adenoviruses into combination cancer therapy: Mechanisms, advances and clinical outlook. [PDF]

Clin Transl Med
Iova V, Iova GM, Tudosie MS, Scrobota I, Smarandache CG.   +4 more
europepmc   +1 more source